indobufen has been researched along with aspirin in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (31.58) | 18.7374 |
| 1990's | 15 (39.47) | 18.2507 |
| 2000's | 3 (7.89) | 29.6817 |
| 2010's | 4 (10.53) | 24.3611 |
| 2020's | 4 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Vinazzer, H | 1 |
| Bergamaschi, M; Ceserani, R; Pierucci, L; Pogliani, E; Spelta, A | 1 |
| Avruscio, GP; Cordiano, I; Fabris, F; Girolami, A; Randi, ML; Steffan, A | 1 |
| Bregani, R; Corneo, G; Fowst, C; Pogliani, EM | 1 |
| Cataldo, G; Marubini, E; Mezzanotte, G; Montoro, C; Petroccione, A; Rovelli, F | 1 |
| Belcaro, G; De Simone, P | 1 |
| Peregrin, J; Pirk, J; Rohn, V | 1 |
| Belcaro, G; Cesarone, MR; De Cenzo, A; Errichi, BM; Laurora, G; Marinucci, R | 1 |
| Cantatore, G; Cerillo, A; Donati, PA; Donzelli, R; Maio, N; Muras, I; Perla, N; Villano, M; Vizioli, L | 1 |
| Grasselli, S; Gresele, P; Guerciolini, R; Iadevaia, V; Nenci, GG; Parise, P | 1 |
| Irwin, JT; Jennings, SA; Lane, IF; McCollum, CN; Meek, AC; Poskitt, KR | 1 |
| Carriero, MR; Cerletti, C; de Gaetano, G; Mussoni, L | 1 |
| Corvi, G; Fuccella, LM; Mandelli, V; Pogliani, E | 1 |
| Carrieri, P; Fioretti, A; Indaco, A; Iorillo, L; Orefice, G | 1 |
| Bergamaschi, M; Branzoli, U; Pierucci, L | 1 |
| Akman, N | 1 |
| Brantmark, B; Hanson, A; Melander, A; Nilsson, C; Wåhlin-Boll, E | 1 |
| Coccheri, S; Morocutti, C | 1 |
| Beton, D; Campbell, C; Critchley, A; Lawson, RA; Nair, U; Rajah, SM; Rees, M; Saunders, N; Walker, D; Williams, G | 1 |
| Braga, M; Cataldo, G; Lavezzari, M; Marubini, E; Pirotta, N; Rovelli, F | 1 |
| Mach, T; Pirk, J; Rohn, V | 1 |
| Bernini, W; Biagi, G; Coccheri, S; De Caterina, R; Giannessi, D; Lavezzari, M; Lazzerini, G; Stragliotto, E | 1 |
| Cipollone, F; Cuccurullo, F; Greco, A; Liuzzo, G; Maseri, A; Padovano, R; Panara, MR; Patrignani, P; Patrono, C; Quaranta, G; Rebuzzi, AG | 1 |
| Alessandrini, P; Bon, GB; Bucciarelli, T; Ciabattoni, G; Cipollone, F; Costantini, F; Davi, G; Mezzetti, A; Minotti, G; Patrono, C | 1 |
| Cataldo, G; Heiman, F; Lavezzari, M; Marubini, E | 1 |
| Cohen, H; Ebrahim, S; Taylor, FC | 1 |
| Prisco, D | 1 |
| Pengo, V | 1 |
| Collet, JP | 1 |
| Bartkova, A; Herzig, R; Hlustik, P; Kanovsky, P; Kovacik, M; Kral, M; Sanak, D; Skoloudik, D; Vlachova, I | 1 |
| Acconcia, MC; Barillà, F; Dominici, T; Gaudio, C; Mangieri, E; Paravati, V; Pellicano, M; Pulcinelli, FM; Tanzilli, G; Torromeo, C | 1 |
| Choi, HI; Lee, JY; Sung, KC | 1 |
| Fang, W; Gou, X; Hou, K; Li, F; Li, Y; Lv, N; Xu, D | 1 |
| Abdus, S; Bai, J; Eikelboom, JW; Gong, X; Gu, Q; Li, C; Lu, Y; Mei, L; Shi, L; Tan, C; Ullah, I; Wang, G; Yang, M; Ye, Z | 1 |
| Bath, PM; Chen, W; Dong, Q; Jiang, Y; Jing, J; Johnston, SC; Li, H; Lin, J; Meng, X; Pan, Y; Wang, Y; Xu, AD | 1 |
| Chen, M; Cheng, K; Ge, J; Huang, J; Lan, J; Li, G; Qian, J; Wang, X; Wang, Y; Wei, G; Wu, H; Xu, L; Zhang, C; Zhang, H; Zhao, X | 1 |
4 review(s) available for indobufen and aspirin
| Article | Year |
|---|---|
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Hemorrhage; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Warfarin | 2001 |
[Thromboembolism in non-rheumatic atrial fibrillation].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Consensus Development Conferences as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Electric Countershock; Female; Hemorrhage; Humans; Incidence; International Normalized Ratio; Isoenzymes; Isoindoles; Male; Membrane Proteins; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thromboembolism; Treatment Outcome; Warfarin | 2001 |
[Management of aspirin discontinuation in stable coronary heart disease prior to elective surgery].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Disease; Cyclooxygenase Inhibitors; Drug Administration Schedule; Drug Monitoring; Elective Surgical Procedures; Flurbiprofen; Humans; Isoindoles; Metabolic Clearance Rate; Phenylbutyrates; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Preoperative Care; Risk Factors; Time Factors | 1999 |
Oral antiplatelet therapy in stroke prevention. Minireview.
Topics: Administration, Oral; Aspirin; Clopidogrel; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2010 |
16 trial(s) available for indobufen and aspirin
| Article | Year |
|---|---|
Indobufen versus dipyridamole plus aspirin in the treatment of patients with peripheral atherosclerotic disease.
Topics: Aged; Arteriosclerosis; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Random Allocation | 1992 |
Bleeding time and antiplatelet agents in normal volunteers.
Topics: Adolescent; Adult; Aspirin; Bleeding Time; Female; Humans; Isoindoles; Male; Phenylbutyrates; Platelet Aggregation Inhibitors; Reference Values; Ticlopidine | 1992 |
A linear model suitable for assessing graft patency in controlled clinical trials. SINBA Group.
Topics: Anastomosis, Surgical; Angiography; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Isoindoles; Models, Statistical; Phenylbutyrates; Platelet Aggregation Inhibitors; Probability; Regression Analysis; Vascular Patency | 1990 |
Long-term evaluation of indobufen in peripheral vascular disease.
Topics: Aspirin; Diabetes Complications; Female; Humans; Intermittent Claudication; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Walking | 1991 |
The effect of ibustrin on early aortocoronary bypass patency.
Topics: Angiography, Digital Subtraction; Aspirin; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Graft Occlusion, Vascular; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Prospective Studies | 1990 |
[Embolic complications in atrial fibrillation. Data of the Studio Italiano Fibrillation Atriale (SIFA)].
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebrovascular Disorders; Embolism; Female; Follow-Up Studies; Humans; Isoindoles; Italy; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Risk Factors; Time Factors; Warfarin | 1995 |
Aspirin and prevention of stroke.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Warfarin | 1994 |
Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
Topics: Adolescent; Adult; Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Postoperative Care; Prospective Studies; Time Factors | 1994 |
Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA).
Topics: Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Female; Graft Occlusion, Vascular; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Prospective Studies; Regression Analysis; Risk Factors; Saphenous Vein | 1993 |
[The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year].
Topics: Adult; Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Female; Graft Occlusion, Vascular; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Time Factors; Vascular Patency | 1993 |
A prostacyclin-sparing effect of indobufen vs. aspirin.
Topics: Adult; Aspirin; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Epoprostenol; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Prospective Studies; Prostaglandins; Reference Values | 1996 |
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina.
Topics: Aged; Angina, Unstable; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Humans; Isoenzymes; Isoindoles; Male; Membrane Proteins; Middle Aged; Phenylbutyrates; Prostaglandin-Endoperoxide Synthases; Reference Values; Thromboxane A2; Thromboxane B2 | 1997 |
Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Isoindoles; Male; Middle Aged; Percutaneous Coronary Intervention; Phenylbutyrates; Platelet Aggregation Inhibitors; Risk Factors; Thromboxane B2; Ticlopidine; Treatment Outcome | 2013 |
Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis.
Topics: Aged; Aspirin; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2 | 2021 |
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial.
Topics: Aspirin; Brain Ischemia; Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome | 2022 |
Indobufen or Aspirin on Top of Clopidogrel After Coronary Drug-Eluting Stent Implantation (OPTION): A Randomized, Open-Label, End Point-Blinded, Noninferiority Trial.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Ischemic Stroke; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Thrombosis; Treatment Outcome; Troponin | 2023 |
18 other study(ies) available for indobufen and aspirin
| Article | Year |
|---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
[Clinical-experimental studies on the inhibition of thrombocyte function with acetylsalicylic acid and with indobufen].
Topics: Aspirin; Humans; Indoles; Isoindoles; Phenylbutyrates; Platelet Aggregation; Platelet Factor 3; Platelet Factor 4 | 1979 |
Indobufen, a new inhibitor of platelet aggregation. Studies in guinea pigs.
Topics: Animals; Aspirin; Blood Platelets; Blood Specimen Collection; Dipyridamole; Guinea Pigs; In Vitro Techniques; Indoles; Indomethacin; Isoindoles; Phenylbutyrates; Platelet Aggregation; Prostaglandins; Prothrombin Time; Serotonin; Thrombin; Thromboxane A2; Time Factors | 1979 |
[Chronic treatment of vascular diseases with indobufen].
Topics: Adult; Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Isoindoles; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Vascular Diseases; Veins | 1989 |
[Prevention of thromboses in vascular microanastomoses. Experimental study on the role of anti-aggregant drugs. Preliminary remarks].
Topics: Animals; Aspirin; Isoindoles; Male; Microsurgery; Phenylbutyrates; Platelet Aggregation Inhibitors; Postoperative Complications; Rats; Rats, Inbred Strains; Thrombosis; Vascular Surgical Procedures | 1988 |
In vitro and ex vivo effects of indobufen on red blood cell deformability.
Topics: Aspirin; Drug Interactions; Erythrocyte Deformability; Humans; In Vitro Techniques; Isoindoles; Phenylbutyrates; Vascular Diseases | 1987 |
Effect of the cyclo-oxygenase inhibitor indobufen on platelet accumulation in prosthetic vascular grafts.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Disease Models, Animal; Dogs; Drug Evaluation; Graft Occlusion, Vascular; Isoindoles; Phenylbutyrates; Platelet Aggregation | 1986 |
Low dose aspirin does not prevent fibrinolytic response to venous occlusion.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Aspirin; Fibrinolysis; Hematocrit; Humans; Isoindoles; Phenylbutyrates; Thrombosis; Thromboxane B2 | 1986 |
Preliminary human pharmacology studies on the inhibition of platelet aggregation by indobufen (K 3920).
Topics: Aspirin; Dose-Response Relationship, Drug; Humans; Indoles; Isoindoles; Oxazoles; Phenylbutyrates; Platelet Aggregation | 1981 |
A comparative study between indobufen and acetylsalicylic acid on beta-thromboglobulin, platelet factor 4 and platelet aggregation in patients with transient ischemic attacks.
Topics: Aspirin; Beta-Globulins; beta-Thromboglobulin; Humans; Ischemic Attack, Transient; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation; Platelet Factor 4 | 1984 |
Inhibitory activity of indobufen (*) on platelet aggregation in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Depression, Chemical; Isoindoles; Lethal Dose 50; Male; Mice; Phenylbutyrates; Platelet Aggregation | 1984 |
The effect of acetylsalicylic acid. Dipyridamole and K 3920 on the secretion of platelet factor 4.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation Factors; Blood Platelets; Collagen; Dipyridamole; Epinephrine; Humans; Indoles; Isoindoles; Phenylbutyrates; Platelet Factor 4 | 1980 |
High-pressure liquid chromatographic determination of acetylsalicylic acid, salicylic acid, diflunisal, indomethacin, indoprofen and indobufen.
Topics: Anti-Inflammatory Agents; Aspirin; Chromatography, High Pressure Liquid; Diflunisal; Humans; Indoles; Indomethacin; Indoprofen; Isoindoles; Phenylbutyrates; Salicylates | 1981 |
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.
Topics: Antioxidants; Aspirin; Cardiovascular Diseases; Cross-Sectional Studies; Cyclooxygenase Inhibitors; Dinoprost; Female; Humans; Hypercholesterolemia; Isoindoles; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Phenylbutyrates; Platelet Activation; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Thromboxane B2; Vitamin E | 1997 |
Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis.
Topics: Aspirin; Coronary Artery Bypass; Cyclooxygenase Inhibitors; Dipyridamole; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Radiography; Randomized Controlled Trials as Topic | 1998 |
[Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Comorbidity; Diabetes Complications; Double-Blind Method; Fibrinolytic Agents; Heart Valve Diseases; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Isoindoles; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thromboembolism; Warfarin | 2001 |
Comparison of aspirin and indobufen in healthy volunteers.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Arachidonic Acid; Aspirin; Blood Platelets; Cross-Over Studies; Drug Administration Schedule; Female; Healthy Volunteers; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prostaglandin-Endoperoxide Synthases; Thromboxane B2 | 2016 |
Pretreatment of Indobufen and Aspirin and their Combinations with Clopidogrel or Ticagrelor Alleviates Inflammasome Mediated Pyroptosis Via Inhibiting NF-κB/NLRP3 Pathway in Ischemic Stroke.
Topics: Animals; Aspirin; Brain Ischemia; Clopidogrel; Inflammasomes; Ischemic Stroke; Isoindoles; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phenylbutyrates; Pyroptosis; Rats; Reperfusion Injury; Stroke; Ticagrelor | 2021 |